Professor Sarah Gilbert to net more than $17m after Oxford's Vaccitech makes US debut
Professor Sarah Gilbert to net more than $17m after Oxford’s Vaccitech makes US debut Vaccitech will start trading on the Nasdaq market later today Professor Sarah Gilbert, one of Vaccitech's co-founders Credit: John Cairns One of the leading figures behind the Oxford/AstraZeneca Covid-19 vaccine is expected to today crystallise a fortune of more than $17m (£12m) as her vaccine company floats in New York. Professor Sarah Gilbert, and her co-founder Adrian Hill, both of whom work at the Jenner Institue and who played significant roles in developing the jab, are set to see their paper wea...